# Type 2 Diabetes Mellitus and Atherosclerosis

> **NCT01250340** · PHASE4 · UNKNOWN · sponsor: **University of Roma La Sapienza** · enrollment: 80 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01250340
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-08
- **Primary completion:** 2011-01
- **Final completion:** 2012-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2012-11-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01250340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01250340, "Type 2 Diabetes Mellitus and Atherosclerosis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01250340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
